XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Non-vested Restricted Stock Units Activity The table below summarizes the restricted stock unit ("RSU") activity for the nine months ended September 30, 2023:

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

Shares

 

 

Fair Value

 

Unvested RSUs—December 31, 2022

 

 

31,288,688

 

 

$

10.34

 

Granted

 

 

12,357,201

 

 

 

8.95

 

Vested

 

 

(5,489,562

)

 

 

10.61

 

Forfeited

 

 

(1,409,181

)

 

 

9.92

 

Unvested RSUs—September 30, 2023

 

 

36,747,146

 

 

 

9.83

 

Summary of Share-based Compensation Arrangements by Share-based Payment Award The table below summarizes the stock option activity for the nine months ended September 30, 2023:

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

Exercise

 

 

Life

 

 

Value

 

 

 

Shares

 

 

Price

 

 

(in years)

 

 

(in thousands)

 

Options outstanding—December 31, 2022

 

 

45,249,260

 

 

$

2.99

 

 

 

4.9

 

 

$

258,470

 

Exercised

 

 

(8,122,930

)

 

 

2.86

 

 

 

 

 

 

 

Forfeited and canceled

 

 

(493,652

)

 

 

6.96

 

 

 

 

 

 

 

Options outstanding—September 30, 2023

 

 

36,632,678

 

 

$

2.96

 

 

 

4.3

 

 

$

380,524

 

Options exercisable—September 30, 2023

 

 

34,638,157

 

 

$

2.79

 

 

 

4.1

 

 

$

365,947

 

Options vested and expected to vest—September 30, 2023

 

 

36,547,087

 

 

$

2.95

 

 

 

4.3

 

 

$

379,910

 

Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount

Stock-Based Compensation—Stock-based compensation expense has been recorded in the accompanying condensed consolidated statements of operations and comprehensive (loss) income as follows for the three and nine months ended September 30, 2023 and 2022 (in thousands):

 

 

 

For the Three Months Ended

 

 

For the Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Cost of revenues

 

$

2,396

 

 

$

1,657

 

 

$

6,595

 

 

$

4,167

 

Research and development

 

 

6,359

 

 

 

5,373

 

 

 

18,833

 

 

 

14,433

 

Sales and marketing

 

 

9,257

 

 

 

6,890

 

 

 

25,264

 

 

 

18,331

 

General and administrative

 

 

21,739

 

 

 

14,802

 

 

 

53,779

 

 

 

43,838

 

Total stock-based compensation expense

 

$

39,751

 

 

$

28,722

 

 

$

104,471

 

 

$

80,769

 

 

2021 Employee Stock Purchase Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of the ESPP purchase rights sold during the nine months ended September 30, 2023 was estimated using the Black-Scholes option pricing model with the following assumptions:

Expected term (in years)

 

0.5

Expected volatility

 

30%—51%

Expected dividend yield

 

0%

Risk-free interest rate

 

2.5%—4.7%